📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Pathogenic variants in actionable MODY genes are associated with type 2 diabetes. (2020)

First Author: Bonnefond A

Attributed to: Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s42255-020-00294-3

PubMed Identifier: 33046911

Publication URI: http://europepmc.org/abstract/MED/33046911

Type: Journal Article/Review

Volume: 2

Parent Publication: Nature metabolism

Issue: 10

ISSN: 2522-5812